IPO Timeline
Broker Deadline
2026-07-02
Morning deadline
HKEX Deadline
2026-07-02
Noon deadline
Broker Results (T-2)
2026-07-03
Some brokers release in afternoon
Grey Market (T-1)
2026-07-06
Afternoon
HKEX Allotment (T-1)
2026-07-06
Evening
Registrar Allotment (T-1)
2026-07-06
Evening
Listing Day (T)
2026-07-07
First day of trading
Company Overview
| Stock Name | 同仁堂醫養 |
|---|---|
| Stock Code | 02667 |
| Company Full Name | 同仁堂醫養 |
| Industry | Biotech & Pharma |
| Principal Activities | 我們是同仁堂旗下一家戰略性聚焦於中國中醫醫療服務的附屬公司，為個人客戶提供全面中醫醫療服務，為機構客戶提供標準化管理服務，並提供各種健康產品及其他產品。 |
| Listing Date | 2026-07-07 |
| Listing Rules Era | New Rules (after Aug 2025) |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | Headquarters and 5th Floor, Tower A, Yonggui Center, No. 47 Guangqumennei Principal Place Street, Dongcheng District, Beijing, PRC of Business in the PRC Principal Place of 40/F, Dah Sing Financial Ce |
| Business Address (Hong Kong) | 香港灣仔皇后大道東248號大新金融中心40樓 |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | yiyang.tongrentang.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | Computershare Hong Kong Investor Services Limited |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism B |
|---|---|
| Offer Price | To be extracted |
| Offer Price Range | HK$ 5.48 - 6.21 |
| Lot Size | 500 shares |
| Entry Threshold | HK$ 4,150 |
| Par Value | RMB 1.0 / shares |
| Offer Period | 2026-06-26 to 2026-07-02 |
| Global Offering Shares | 108,153,500 shares |
| HK Public Offer Shares (Initial) | 10,815,500 shares (10.0%) |
| Public Offer Lots (Initial) | 21,631lots (10,815lots, 10,816lots) |
| International Placing Shares (Initial) | 97,338,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 465,362,049 shares |
| Greenshoe (Over-allotment Option) | No |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 0% |
| Clawback Tiers | 机制B：无回补机制 |
| Reallocation Option | No |
| Total Global Offering Size | HK$ 671,633,235 |
Subscription Tiers
Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.
Pool A
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1 lots | 500 | HK$ 3,105 |
| 2 lots | 1,000 | HK$ 6,210 |
| 3 lots | 1,500 | HK$ 9,315 |
| 4 lots | 2,000 | HK$ 12,420 |
| 5 lots | 2,500 | HK$ 15,525 |
| 6 lots | 3,000 | HK$ 18,630 |
| 7 lots | 3,500 | HK$ 21,735 |
| 8 lots | 4,000 | HK$ 24,840 |
| 9 lots | 4,500 | HK$ 27,945 |
| 10 lots | 5,000 | HK$ 31,050 |
| 12 lots | 6,000 | HK$ 37,260 |
| 14 lots | 7,000 | HK$ 43,470 |
| 16 lots | 8,000 | HK$ 49,680 |
| 18 lots | 9,000 | HK$ 55,890 |
| 20 lots | 10,000 | HK$ 62,100 |
| 30 lots | 15,000 | HK$ 93,150 |
| 40 lots | 20,000 | HK$ 124,200 |
| 50 lots | 25,000 | HK$ 155,250 |
| 60 lots | 30,000 | HK$ 186,300 |
| 70 lots | 35,000 | HK$ 217,350 |
| 80 lots | 40,000 | HK$ 248,400 |
| 90 lots | 45,000 | HK$ 279,450 |
| 100 lots | 50,000 | HK$ 310,500 |
| 120 lots | 60,000 | HK$ 372,600 |
| 140 lots | 70,000 | HK$ 434,700 |
| 160 lots | 80,000 | HK$ 496,800 |
| 180 lots | 90,000 | HK$ 558,900 |
| 200 lots | 100,000 | HK$ 621,000 |
| 400 lots | 200,000 | HK$ 1,242,000 |
| 600 lots | 300,000 | HK$ 1,863,000 |
| 800 lots | 400,000 | HK$ 2,484,000 |
| 1,000 lots | 500,000 | HK$ 3,105,000 |
| 1,200 lots | 600,000 | HK$ 3,726,000 |
| 1,400 lots | 700,000 | HK$ 4,347,000 |
| 1,600 lots | 800,000 | HK$ 4,968,000 |
Pool B
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1,800 lots | 900,000 | HK$ 5,589,000 |
| 2,000 lots | 1,000,000 | HK$ 6,210,000 |
| 4,000 lots | 2,000,000 | HK$ 12,420,000 |
| 6,000 lots | 3,000,000 | HK$ 18,630,000 |
| 10,815 lots | 5,407,500 | HK$ 33,580,575 |
Valuation & Financials
| Market Cap (at Offer Price) | HK$ 3,862,505,006 |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | 不適用（公司处于亏损状态） |
| Profit/Loss Status | 盈利約人民幣46.2百萬元 |
| Period-End Cash Balance | 人民币326,200,000元 |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | Loading... |
|---|---|
| First Day Open | HK$ -- |
Use of Proceeds
| Use of Proceeds | 1、約47.5%（或366.2百萬港元）將用于擴充公司的中醫醫療服務網絡； 2、約23.6%（或182.1百萬港元）預期將于2025年至2029年用于提升公司的中醫醫療服務能力； 3、約18.9%（或145.6百萬港元）預期將用于償還若干未償還銀行貸款； 4、約10.0%（或77.1百萬港元）將用作營運資金及其他一般企業用途。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
中国国际金融香港证券有限公司 CE AEN894(sole)
Overall Coordinators (1)
中国国际金融香港证券有限公司 CE AEN894(sole)
Joint Global Coordinators (3)
中国国际金融香港证券有限公司 CE AEN894
工银国际证券有限公司 CE ARO299
广发证券（香港）经纪有限公司
Joint Bookrunners (6)
中国国际金融香港证券有限公司 CE AEN894
工银国际证券有限公司 CE ARO299
广发证券（香港）经纪有限公司
农银国际融资有限公司 CE AWL249
西牛证券有限公司 CE BHT553
百惠证券有限公司 CE BPQ161
Joint Lead Managers (9)
中国国际金融香港证券有限公司 CE AEN894
工银国际证券有限公司 CE ARO299
广发证券（香港）经纪有限公司
农银国际证券有限公司 CE ACX411
西牛证券有限公司 CE BHT553
百惠证券有限公司 CE BPQ161
富途证券国际（香港）有限公司 CE AZT137
利弗莫尔证券有限公司 CE BJN764
老虎证券（香港）环球有限公司 CE BMU940
Service Providers
| Role | Institution |
|---|---|
| Legal Advisor to Company |
天元律师事务所（有限法律责任合伙） 天元律师事务所 通商律师事务所 |
| Legal Advisor to Sponsors/Underwriters |
海问律师事务所有限法律责任合伙 汉坤律师事务所 |
| Auditor and Reporting Accountant | 安永会计师事务所 |
| Industry Advisor | 弗若斯特沙利文（北京）咨询有限公司 |
| Compliance Advisor | 浤博资本有限公司 CE BPB716 |
| Receiving Banks |
中国银行（香港）有限公司 中国工商银行（亚洲）有限公司 |
| H Share Registrar | 香港中央证券登记有限公司 |
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | 港科创投资集团有限公司 | — | — | — | — | 6 months | 2027-01-07 |
| 2 | Management Company Pte Ltd | — | — | — | — | 6 months | 2027-01-07 |
| 3 | 最终客户包括北京仟草中药饮片有限公司 | — | — | — | — | 6 months | 2027-01-07 |
Directors & Management
| Chairman | Mr. Rao Zuhai |
|---|---|
| Company Secretary | 喬雅楠 |
執行董事 (3)
| # | Name | English Name | Type |
|---|---|---|---|
| 1 | 饶祖海 | — | 執行董事 |
| 2 | 鲁喦 | — | 執行董事 |
| 3 | 桂嬗 | — | 執行董事 |
非執行董事 (3)
| # | Name | English Name | Type |
|---|---|---|---|
| 1 | 朱峰 | — | 非執行董事 |
| 2 | 孙恺 | — | 非執行董事 |
| 3 | 邢茜 | — | 非執行董事 |
獨立非執行董事 (3)
| # | Name | English Name | Type |
|---|---|---|---|
| 1 | 严志雄 | — | 獨立非執行董事 |
| 2 | 张翔 | — | 獨立非執行董事 |
| 3 | 高彦彬 | — | 獨立非執行董事 |
Major Shareholders
| Major Shareholders & Holdings | Controlling Shareholders pursuant to Rule 10.07 of the Listing Rules, see “Underwriting — Underwriting Arrangements — Hong Kong Public Offering — Undertakings pursuant to the Listing Rules — (B) Undertakings by the Controlling Shareholders.” GENERAL MANDATE TO ISSUE SHARES |
|---|
Offering Structure
Subscription Tiers
IPO Timeline
